Marcos S Cardoso

6PUBLICATIONS
31CO-AUTHORS
Innate immunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)MechanobiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 23, 2025
Type I IFN drives neutrophil swarming, impeding lung T cell-macrophage interactions and TB control.

William J Branchett, Evangelos Stavropoulos, Jessica Shields

|Jun 26, 2024
CD5L is upregulated upon infection with Mycobacterium tuberculosis with no effect on disease progression.

Marcos S Cardoso, Rute Gonçalves, Liliana Oliveira

|May 15, 2024
CD5L as a promising biological therapeutic for treating sepsis.

Liliana Oliveira, M Carolina Silva, Ana P Gomes

|Oct 14, 2019
Myeloid HIF-1α regulates pulmonary inflammation during experimental Mycobacterium tuberculosis infection.

Mariana Resende, Catarina M Ferreira, Ana Margarida Barbosa

|Sep 29, 2019
TNF-Mediated Compensatory Immunity to <i>Mycobacterium avium</i> in the Absence of Macrophage Activation by IFN-γ.

Mariana Resende, Marcos S Cardoso, Ricardo Fróis-Martins

|Jul 09, 2017
Innate IFN-γ-Producing Cells Developing in the Absence of IL-2 Receptor Common γ-Chain.

Mariana Resende, Marcos S Cardoso, Ana R Ribeiro

Pageof 1